Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Learn how to effectively use points for travel rewards. Discover tips to maximize your savings and enjoy incredible travel experiences.
17,578 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
The Palmetto State signs a sweeping digital-asset measure banning CBDC use by state agencies and doubling down on cry...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
A quiet, disciplined bet on the entire U.S. equity landscape. Pennington Partners increasing its stake in VTHR highli...
Canopy Growth is restating two years of earnings ahead of June earnings. This article breaks down what it means, how ...
Wall Street’s bearish take on Plug Power stock has critics unsure. This article builds a practical bull case, showing...
Democrats press an anti-corruption platform as fresh stock-trade disclosures draw scrutiny of lawmakers. The debate t...
A $275,000 portfolio that pays around 9% could replicate the average Social Security check, but the strategy carries ...
Mercadolibre stock down strong after a mixed reaction to solid quarterly results. This article breaks down why growth...
When bond yields spiking higher, stock prices can face pressure, especially for growth-focused names. This guide brea...
Hypernova has closed a $3 million pre-seed round to bring a hyperliquid-based prop trading platform to market, promis...
Bitcoin often sparks fierce arguments: is it dead or just resting? This article breaks down three substantial concern...